Richard Jeffs bought $3,310 of STME
owner at Cell MedX Corp.. 19,399 shares at an average of $0.17, traded Feb 21, 2025, filed Feb 25, 2025.
Score components
- +12Role10% owner
- 0Trade size$3k at market
- 0Relative to holdingsHoldings up 1.2%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -47.1%, 3m -18.0%, 6m -42.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001626533-25-000001, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | FTax withholding Common Shares | -239,160,254 | $0.00 | $0 | 1,708,288 | Feb 25, 2025 |
| Feb 21, 2025 | POpen-market purchase Common Shares | -15,000 | $0.16 | $2,430 | 1,693,288 | Feb 25, 2025 |
| Feb 24, 2025 | POpen-market purchase Common Shares | -4,399 | $0.20 | $880 | 1,688,889 | Feb 25, 2025 |
Related signals
Other insiders at Cell MedX Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | STMEsell Cell MedX Corp. | Amir Vahabzadeh director, owner | $5,667 16,667 shares | -0% | |
| 57Moderate | Cell MedX Corp. | David Jeffs Chief Executive Officer | $105k 15,000,000 shares | +20% | |
| 43Moderate | Cell MedX Corp. | Richard Jeffs owner | $101k 14,372,285 shares | +128% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.